Monday, May 9, 2011
Med BioGene Inc., of Vancouver, British Columbia, reported a nonbrokered private placement of a maximum of $300,000 of units. Each unit will be issued at a price of 5 cents and will consist of one common share and one-half of one common share purchase warrant.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.